Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network ...

Food technology and ingredients company Kerry Group has reported revenues of €8 billion for 2024 and said it remains well positioned for a strong market outperformance this year.

Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for ...

Revenue at Kerry Group fell slightly last year as volume growth of 3.3 per cent was partly offset by falling prices. The group said revenue totalled €7.98 billion for the year, down 0.5 per cent ...

Since it was founded in 2008, ViClarity has become a major player in RegTech while strengthening its roots in Kerry ...

Astellas Ireland, a wholly owned subsidiary of Astellas Pharma Inc has been in Killorglin, Co Kerry, since 1990. The company ...

Leading pharmaceutical excipient producers, Kerry Bio-Science Sheffield™ Pharma Ingredients and Foremost Farms USA® announced today that they have formed a strategic marketing alliance which will ...